These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31906331)

  • 41. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Effects of Calcium Hydroxide-loaded Poly(Lactic-co-glycolic Acid) Biodegradable Nanoparticles in the
    Chaiyosang P; Mahatnirunkul T; Leelapornpisid W
    J Contemp Dent Pract; 2023 Jun; 24(6):351-356. PubMed ID: 37534500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation of uniform-sized GeXIVA[1,2]-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency.
    Li L; Li Z; Guo Y; Zhang K; Mi W; Liu J
    Drug Deliv; 2022 Dec; 29(1):2283-2295. PubMed ID: 35866254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained release of melatonin from poly (lactic-co-glycolic acid) (PLGA) microspheres to induce osteogenesis of human mesenchymal stem cells in vitro.
    Zhang L; Zhang J; Ling Y; Chen C; Liang A; Peng Y; Chang H; Su P; Huang D
    J Pineal Res; 2013 Jan; 54(1):24-32. PubMed ID: 22712496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
    Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanistic Analysis of Temperature-Dependent Curcumin Release from Poly(lactic-co-glycolic acid)/Poly(lactic acid) Polymer Nanoparticles.
    Sunazuka Y; Ueda K; Higashi K; Wada K; Moribe K
    Mol Pharm; 2024 Mar; 21(3):1424-1435. PubMed ID: 38324797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Separable Microneedles for Near-Infrared Light-Triggered Transdermal Delivery of Metformin in Diabetic Rats.
    Zhang Y; Wang D; Gao M; Xu B; Zhu J; Yu W; Liu D; Jiang G
    ACS Biomater Sci Eng; 2018 Aug; 4(8):2879-2888. PubMed ID: 33435011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs.
    Jensen JT; Reinecke I; Post TM; Lukkari-Lax E; Hofmann BM
    Contraception; 2023 Apr; 120():109954. PubMed ID: 36634730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fabrication of separable microneedles with phase change coating for NIR-triggered transdermal delivery of metformin on diabetic rats.
    Liu T; Jiang G; Song G; Zhu J; Yang Y
    Biomed Microdevices; 2020 Jan; 22(1):12. PubMed ID: 31912303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro stress effect on degradation and drug release behaviors of basic fibroblast growth factor--poly(lactic-co-glycolic-acid) microsphere.
    Xiong Y; Yu Z; Lang Y; Hu J; Li H; Yan Y; Tu C; Yang T; Song Y; Duan H; Pei F
    Drug Des Devel Ther; 2016; 10():431-40. PubMed ID: 26869764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of lysozyme loaded microneedles for dermal applications.
    Panda A; Shettar A; Sharma PK; Repka MA; Murthy SN
    Int J Pharm; 2021 Jan; 593():120104. PubMed ID: 33278495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery.
    Thalhauser S; Peterhoff D; Wagner R; Breunig M
    Eur J Pharm Biopharm; 2020 Nov; 156():1-10. PubMed ID: 32860903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Controlled Release of Lysozyme from Double-Walled Poly(Lactide-Co-Glycolide) (PLGA) Microspheres.
    Ansary RH; Rahman MM; Mohamad N; Arrif TM; Latif AZA; Katas H; Nik WSBW; Awang MB
    Polymers (Basel); 2017 Oct; 9(10):. PubMed ID: 30965787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fabrication of Circular Obelisk-Type Multilayer Microneedles Using Micro-Milling and Spray Deposition.
    Kim MJ; Park SC; Rizal B; Guanes G; Baek SK; Park JH; Betz AR; Choi SO
    Front Bioeng Biotechnol; 2018; 6():54. PubMed ID: 29868571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incorporating surfactants into PCL microneedles for sustained release of a hydrophilic model drug.
    Bader N; Abu Ammar A
    Int J Pharm; 2024 Mar; 652():123826. PubMed ID: 38253267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel/poly (lactic-co-glycolic acid) nanoparticle composites.
    Hsu MN; Luo R; Kwek KZ; Por YC; Zhang Y; Chen CH
    Biomicrofluidics; 2015 Sep; 9(5):052601. PubMed ID: 25825623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A biomimetic approach to active self-microencapsulation of proteins in PLGA.
    Shah RB; Schwendeman SP
    J Control Release; 2014 Dec; 196():60-70. PubMed ID: 25219750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles.
    Seok H; Noh JY; Lee DY; Kim SJ; Song CS; Kim YC
    J Control Release; 2017 Nov; 265():66-74. PubMed ID: 28434892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.